IMMUNOGENICITY AND SAFETY STUDY OF 1 AND 2 DOSES OF GLAXOSMITHKLINE (GSK) BIOLOGICALS' MENINGOCOCCAL VACCINE MENACWY-TT (GSK134612) IN TODDLERS, PERSISTENCE UP TO 5 YEARS AFTER VACCINATION AND CO-ADMINISTRATION WITH PFIZER'S PREVENAR 13™VACCINE: